Vimta Labs (VIMTALABS) Stock Overview

Vimta Labs Limited provides contract research and testing services in India and internationally. It offers product discovery/development, post approval/marketing, preclinical/early development/study, clinical research and development, drug life cycle management support, bioanalytical, analytical, central lab, genetically modified organisms testing, clinical diagnostics, environment testing, preclinical research and testing, food testing and analytical development, and EMI/EMC testing services, as well as IND/505 (b)(2) enabling/studies; IVPT, IVRT, and IVBE studies; and testing services for dioxins and furans, trace heavy metals, label claims, radioactive isotopes, vitamins and minerals, packaging, and shelf life. The company provides solutions to agriculture, electricals and electronics, medical devices, speciality chemicals, biologics and biosimilars, environment, health and safety, nutraceuticals, water and beverages, crop care, food, packaging, clinical diagnostics, home and personal care, and pharmaceuticals industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.